Celltrion, Foreign Investors Net Buy 102,160 Shares in Last 5 Days... Stock Price 288,500 KRW (-0.52%)

As of 12:30 PM on the 16th, Celltrion is trading at 288,500 KRW, down 0.52% from the previous day. The trading volume is 374,635 shares, which is about 45.7% of the previous day's volume. Celltrion is known as a manufacturer of protein and biopharmaceutical products.

On November 11, Shin Jae-hoon, a researcher at Hanwha Investment & Securities, stated, "？ Sales are strong due to preparations for the sales of Remsima SC and stable sales of Remsima IV. Of the total TEVA Azovi contract amounting to 115.6 billion KRW, 46.5 billion KRW was generated in Q3. ？ Sales composition is Remsima 23%, Remsima SC 38%, Truxima 4%, Herzuma 4%, TEVA 8%, Celltrion Pharm 10%, others 13%. ？ Operating profit shows high profitability maintained continuously due to increased profit scale from sales growth and improved production efficiency from the full-scale operation of the first plant expansion," and set Celltrion's target price at 450,000 KRW.

Over the past five days, individual investors have net sold 4,841 shares of Celltrion, while foreigners and institutions have net bought 102,160 shares and net sold 62,119 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.